Articles
According to a recent World Health Organization study, countries must allocate at least six percent of their GDP to research and development to be considered to have a healthy investment in this area. As Mexico currently only invests 1.8 percent of its GDP into R&D, there is clearly still a long road to travel. However,…
"80 percent of our health expenditures are used to treat only 20 percent of the Mexican population"
Representatives of Olivares, one of the leading law firms in Mexico, explain the evolving status of cannabis and narcotics for medicinal use in the country. A new Bill authorizing the use of cannabis for medical treatments was passed by the Senate in December 2016, but there is still a long way to go before it,…
The Mexican pharmaceutical market’s capacity to change dramatically in a short period of time means that both innovators and generics companies must think strategically and “play their cards right” in order to succeed. From 2014 to 2015, the total Mexican pharmaceutical market displayed a strong 5.3 percent growth to reach 209.5 billion Mexican pesos [USD…
Mexico’s medical device segment displays promising growth indicators, with innovative companies providing integrated and digital solutions now firmly embedded within the healthcare landscape. However, regulatory obstacles as well as a lack of joined-up thinking in the public sector remain in place; potentially restricting the industry from realising its full potential. “From 2010 to 2015 the…
Although the country is moving in the right direction with regards to universal coverage, a number of barriers to effective implementation remain. 57.3 million previously uninsured Mexicans are now enrolled in Seguro Popular Gabriel O’Shea, Seguro Popular Healthcare is one of the next items on President Peña Nieto’s busy agenda. The objective: moving Mexico towards…
